The Influence of Hormone Replacement Therapy and Supervised Exercise Training on Body Composition, Cardiovascular Risk and Insulin Sensitivity in Postmenopausal Women

Launched by UNIVERSITY HOSPITAL, GHENT · Apr 25, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring how hormone replacement therapy (HRT) and supervised exercise training can affect body weight, heart health, and insulin sensitivity in postmenopausal women. Researchers want to find out if combining these two approaches can help improve health outcomes for women who have gone through menopause.

To be eligible for the study, participants must be postmenopausal women in good general health, with a body mass index (BMI) between 20 and 30. Women who are not yet in menopause or have a BMI that falls outside this range will not be able to participate. Those who join the trial can expect to engage in supervised exercise sessions and receive hormone therapy, all while being monitored for changes in their health. This study is currently looking for volunteers, so if you meet the criteria and are interested in improving your health, this could be a great opportunity!

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Postmenopausal women
• • Good general health
• • BMI: 20-30 kg/m2
• • Only the use of cholesterol-, blood pressure- or/and thyroid-regulating medication is permitted
• Exclusion Criteria:
• • Women who are not yet in the menopause
• • BMI \<20- and \>30 kg/m2
• • Use of any other medication than cholesterol-, blood pressure- and thyroid-regulating medication